HRNR and neoplasm: Compared to either untreated or non-targeting controls, cells lacking HRNR or CDCA8 showed significantly reduced proliferation (Figure 3B); by contrast, the loss of KRT14 did not affect proliferation, suggesting that it was not required for tumour cell viability or growth.